Gene Synthesis Service
Compared to conventional molecular cloning methods, gene synthesis saves time and effort in obtaining target genes. Four service formats cover simple to complex sequences – from 100 bp fragments to constructs of up to 200 kb.
■Gene Synthesis
Standard Gene Synthesis
Gene SynthesisCompared to conventional molecular cloning methods, gene synthesis saves time and effort in obtaining target genes. Our standard gene synthesis service offers personalized synthesis plans and services tailored to different lengths and application requirements. Simply provide the DNA sequence you need to synthesize, and we assure prompt delivery of the ideal plasmid containing your target gene.
A cost-effective solution through Tsingke’s comprehensive nucleic acid synthesis industrial chain.
images/molecular-biology/standard-gene-synthesis-main.jpgWorkflow
Service Details
Standard Gene Synthesis – Turnaround time5 length ranges
| Length | Turnaround time (calendar days)* |
|---|---|
| < 1.5 kb | 5~8 |
| 1.5 kb~3 kb | 7~11 |
| 3 kb~6 kb | 10~15 |
| 6 kb~8 kb | 15~22 |
| > 8 kb | Evaluation |
Deliverables
Value Added Services
ProLongGene
Gene SynthesisTsingke leads in addressing challenges in gene synthesis, focusing on advancing long-fragment synthesis and assembly technologies. In gene synthesis, where chemical methods limit lengths to 200 nucleotides, we excel in achieving kilobase to megabase-level genes, even entire genomes, through advanced in vitro assembly technologies. With extensive expertise and ongoing innovation, we’ve surpassed gene synthesis boundaries.
Our breakthroughs include mastering yeast assembly for multiple segments and large fragments, enabling precise and efficient one-step assembly of DNA fragments in Saccharomyces cerevisiae. We proficiently produce industrial-scale 50 kb large fragment DNA, demonstrating the capability to deliver fragments up to 200 kb.
images/molecular-biology/prolonggene-main.jpgWorkflow
images/molecular-biology/prolonggene-workflow.jpgService Details
ProLongGene – Turnaround time1 item
| Length | Turnaround time (calendar days) | Vector |
|---|---|---|
| > 10 kb | Evaluation | pCC1413 |
Deliverables
Applications
DNA Fragment
Gene SynthesisTsingke’s DNA Fragment Service provides double-stranded DNA fragments, accommodating lengths of up to 1,200 base pairs. This service caters to the requirements of straightforward gene construction or modification, empowering you to accelerate your research and development activities for various applications such as antibody development, CRISPR-mediated genome editing, and NGS controls.
images/molecular-biology/dna-fragment-main.jpgService Details
DNA Fragment – Turnaround time1 item
| Length | Turnaround time (calendar days) |
|---|---|
| 100 bp~1.2 kb | 2~3 |
Deliverables
Applications
Single-Stranded DNA (ssDNA)
Gene SynthesisRecent research highlights the effectiveness of single-stranded DNA (ssDNA) as a homology-directed repair donor template in CRISPR gene editing. Compared to double-stranded DNA (dsDNA), using ssDNA as a template for homologous recombination will achieve a 9-fold higher CRISPR/Cas9 gene knock-in efficiency compared to dsDNA, and ssDNA is versatile in various biological reactions, especially in DNA nanotechnology.
Tsingke now provides top-notch, sequence-validated ssDNA to enhance the efficiency of your CRISPR experiments.
images/molecular-biology/ssdna-main.jpgService Details
Single-Stranded DNA – Turnaround time6 length ranges
| Length (nt) | Turnaround time (business days) |
|---|---|
| 101~240 | 10 |
| 241~1000 | 15 |
| 1001~3000 | 22 |
| 3001~4000 | 28 |
| 4001~5000 | 32 |
| > 5000 | Evaluation |
Deliverables
Applications
In CRISPR and CRISPR-Cas9 genome editing experiments, long ssDNA serves as a potent donor template, enhancing both insertion and gene replacement efficiency. Its applications extend to single-strand conformation polymorphism, in vitro transcription studies, nucleic acid enzyme S1 mapping, probe preparation, labeling, and differential hybridization. Beyond experiments, ssDNA plays a role in DNA nanotechnology, serving as a scaffold for drug delivery, molecular diagnostics, DNA-based data storage, and diverse nanoscale applications. With a lower risk of random integration, ssDNA is particularly suitable for gene editing in primary cells, stem cells, and the creation of genetically modified animal models.
Gene Cloning Service
PCR cloning and subcloning are techniques commonly used in molecular biology to amplify and manipulate DNA fragments for gene cloning, sequencing and functional analysis, while site-directed mutagenesis is a powerful tool to efficiently enhance the expression, traits, and characterization of the targeted protein. Tsingke offers a comprehensive service encompassing gene synthesis, vector construction, and cloning, which ensures heightened efficiency throughout the entire process.
■Gene Cloning
images/molecular-biology/cloning-overview-main.jpgPCR Cloning & Subcloning
Gene CloningPCR cloning and subcloning are common molecular biology techniques for amplifying and manipulating DNA fragments, including gene cloning, sequencing, and functional analysis. PCR cloning uses the polymerase chain reaction to amplify a specific DNA fragment without requiring specific restriction enzyme sites. Subcloning involves transferring a DNA fragment from one vector to another.
Tsingke offers a one-stop service ranging from gene synthesis and vector construction to cloning and subcloning. Our advanced technology and extensive experience ensure high-quality cloning services.
images/molecular-biology/pcr-cloning-main.jpgService Details
PCR Cloning & Subcloning – Turnaround time5 length ranges
| Length | Turnaround time (calendar days) |
|---|---|
| < 1.5 kb | 7~10 |
| 1.5 kb~3 kb | 7~11 |
| 3 kb~6 kb | 10~15 |
| 6 kb~8 kb | 13~18 |
| > 8 kb | Evaluation |
Deliverables
Applications
Mutagenesis
Gene CloningSite-directed mutagenesis, a molecular biology technique, could deliberately introduce precise changes or mutations into a specific DNA sequence. This includes base insertions, deletions, and point mutations. The technology of site-directed mutagenesis is now extensively employed in the investigation of protein functional site structures, optimization of enzyme activity, understanding of DNA component functions and interactions, as well as applications in gene therapy and other research areas.
Tsingke provides specialized and cost-effective site-directed mutagenesis services, precisely introducing your required mutations for any gene template and any target number of mutations. This facilitates increased experimental efficiency and cost-effectiveness for your research endeavors.
images/molecular-biology/mutagenesis-main.jpgService Details
Mutagenesis – Turnaround time5 length ranges
| Length | Turnaround time (calendar days) |
|---|---|
| < 1.5 kb | 7~10 |
| 1.5 kb~3 kb | 7~11 |
| 3 kb~6 kb | 10~15 |
| 6 kb~8 kb | 13~18 |
| > 8 kb | Evaluation |
Deliverables
Applications
Plasmid Preparation
Research grade and transfection grade plasmid preparation, from microgram to gram scale, with high supercoil content and low endotoxin level.
■Plasmid Preparation
Plasmid Preparation
Plasmid PreparationPlasmids are small, circular DNA molecules used as vectors in DNA recombination. In molecular biology, the target gene is inserted into a plasmid’s multiple cloning sites, forming a recombinant plasmid. This can enter recipient cells, undergo replication and expression, and transfer to progeny cells during host cell division. Plasmid quantity and purity may vary, emphasizing the importance of obtaining high-quality plasmids for successful experiments.
Tsingke offers research grade and transfection grade plasmid preparation services to satisfy different downstream applications’ requirements.
images/molecular-biology/plasmid-prep-main.jpgChoose a Grade
Research Grade
Obtain increased quantities of plasmid (default concentration 1000 ng/μL).
- Supercoil content > 50%
Transfection Grade
Removes endotoxin, increases supercoil ratio, and achieves highly efficient cell transfection.
- Supercoil content > 85%
- Endotoxin < 0.1 / < 0.01 / < 0.005 EU/μg
- LAL test and NGS contamination check
Workflow
Service Details
Turnaround time by volume – Research Grade vs. Transfection Grade12 volumes
| Volume | Research Grade (calendar days)* | Transfection Grade (calendar days)* |
|---|---|---|
| 100 μg | 5 | 5 |
| 200 μg | 6 | 6 |
| 500 μg | 8 | 8 |
| 1 mg | 8 | 8 |
| 2 mg | 9 | 9 |
| 3 mg | 10 | 10 |
| 4 mg | 11 | 11 |
| 5 mg | 12 | 12 |
| 10 mg | 15 | 15 |
| 20 mg | 16 | 17 |
| 50 mg | 17 | 19 |
| 100 mg | 21 | 22 |
Quality Control
Quality control specifications10 items
| Items | Method | Research Grade | Transfection Grade |
|---|---|---|---|
| Appearance | Visual inspection | Colorless liquid of pure transparency | Colorless liquid of pure transparency |
| A260/280 ratio | UV absorbance | 1.8~2.0 | 1.8~2.0 |
| Supercoil content | Agarose gel electrophoresis | > 50% | > 85% |
| Concentration | UV absorbance | 90%~110% | 90%~110% |
| Residual DNA | Agarose gel electrophoresis | Not visible | Not visible |
| Residual RNA | Agarose gel electrophoresis | Not visible | Not visible |
| Restriction enzyme analysis | Agarose gel electrophoresis | Adjustable according to requirement | Adjustable according to requirement |
| Sequence verification | Sanger sequencing | Consistent with the confirmed plasmid sequence | Consistent with the confirmed plasmid sequence |
| Endotoxin | Limulus amebocyte lysate (LAL) test | — | Endotoxin ≤ standard (< 0.1 / < 0.01 / < 0.005 EU/μg) |
| Exogenous contamination detection | NGS (depth > 30×) | — | Genomic DNA < 1%; other DNA contamination < 0.1% |
Deliverables
Resource Center
Codon optimization case studies and a selection of publications citing Tsingke gene synthesis services.
■Resource Center
Codon Optimization
Case studiesCodon optimization is provided free of charge with Tsingke’s gene synthesis service. The two cases below show how it affects protein expression and solubility.
Case 1 – Enhanced protein expression after codon optimization
images/molecular-biology/codon-optimization-case-1.jpgThe target protein 16.8 kDa was not expressed before codon optimization, but was highly expressed after codon optimization.
Case 2 – Codon optimization enhances protein soluble expression
images/molecular-biology/codon-optimization-case-2.jpgThe target protein 100 kDa was expressed in inclusion bodies before codon optimization, and the supernatant was 75% soluble after codon optimization.
Citation
PublicationsTsingke has been cited in numerous journals such as Nature, Cell, Science, and others, totaling thousands of citations.
Below are some publication details from customers who have placed gene synthesis service orders.
Selected publications10 items
| No. | Journal | Impact Factor | Title | DOI |
|---|---|---|---|---|
| 1 | Nature Biotechnology | 68.164 | Strand-selective base editing of human mitochondrial DNA using mitoBEs | 10.1038/s41587-023-01791-y |
| 2 | Science | 56.9 | Structure of the human PKD1-PKD2 complex | 10.1126/science.aat9819 |
| 3 | Science | 56.9 | Enhancing rice panicle branching and grain yield through tissue-specific brassinosteroid inhibition | 10.1126/science.adk8838 |
| 4 | Mol Cancer | 41.44 | A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR | 10.1186/s12943-023-01719-9 |
| 5 | Circulation | 39.9 | Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries | 10.1161/CIRCULATIONAHA.122.059304 |
| 6 | Journal of Infection | 38.637 | MAMDC2, a gene highly expressed in microglia in experimental models of Alzheimer’s Disease, positively regulates the innate antiviral response during neurotropic virus infection | 10.1016/j.jinf.2021.12.004 |
| 7 | Signal Transduction and Targeted Therapy | 38.1196 | UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma | 10.1038/s41392-021-00594-4 |
| 8 | Signal Transduction and Targeted Therapy | 38.1196 | O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner | 10.1038/s41392-023-01316-8 |
| 9 | Signal Transduction and Targeted Therapy | 38.1196 | Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction | 10.1038/s41587-023-01791-y |
| 10 | Signal Transduction and Targeted Therapy | 38.1196 | Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer | 10.1126/science.aat9819 |
Technology & Quality
Technology platforms, manufacturing capacity and quality credentials of our strategic partner Shanghai Yeasen Biotechnology.
■Company Profile
Company Positioning & Company Culture
Shanghai Yeasen BiotechnologyTo serve the life science industry, and to be innovators of life science tools.
Life Science Industry Pyramid
Mission, Vision & Value
To enable success of our customers. Together to make a healthier and brighter world.
Innovating in the life science tools industry.
- Integrity
- Altruism
- Innovation
- Collaboration
- Endeavour
Company Location & Customers
Shanghai Yeasen BiotechnologyResearch and development centers, manufacturing bases and warehouses in China, Singapore and the USA serve more than 20,000 clients and individual labs.
Company Location
images/molecular-biology/yeasen-wuhan-site.jpgShanghai, China
- Enzyme Evolution RDC
- Protein/Antibody RDC
- IVD RDC
- Nucleic acid RDC
- NGS RDC
- 2 manufacture bases
Wuhan, China
- Ultra Clean Factory for Molecular Enzyme
- mRNAtools manufacture base
- Biolink Internet Center
Singapore
- SG Warehouse
USA
- Maryland Business and Warehousing Center
- Overseas R&D Center (under preparation)
Customers
■Technology Platforms
Technology Platform
Shanghai Yeasen BiotechnologyYeasen has built six technical platforms, and built an innovation system covering the underlying technology and applied technology.
Directed Evolution & Rational Design of Molecular Enzymes Platform
- Rational design of molecular enzyme
- Directed evolution of molecular enzyme based on ultra-high-throughput single-cell sorting system
High Density Fermentation & Ultra-clean Protein Purification Platform
- Molecular enzyme high density fermentation technology
- Ultra-clean molecular enzyme production technology (DNA-free, DNase/RNase free)
Molecular IVD Platform
- 3D-Optimizing of molecular diagnostic reagent
- Freeze-drying technology for diagnostic preparations
NGS Library Preparation Platform
- Enzymatic digestion method for NGS library preparation
- Ultra-fast RNA library construction technology
mRNA Preparation Platform
- mRNA stock solution preparation and analysis technology
- mRNA LNP preparation and evaluation technology
High-quality Monoclonal Antibody Platform
- Hybridoma monoclonal antibody preparation technology
- Phage display technology
- Single B cell antibody preparation technology
Rational Design & Directed Evolution
ZymeEditor PlatformZymeEditor Protein Directed Evolution and Rational Design Platform.
images/molecular-biology/yeasen-rational-design.jpg
images/molecular-biology/yeasen-single-cell-sorting.jpgMolecular Diagnostic Platform
YeasenHighlights: 3D-Optimizing of molecular diagnostic reagents and freeze-drying technology.
Advantages
images/molecular-biology/yeasen-md-reagents.jpg
images/molecular-biology/yeasen-freeze-drying-beads.jpgNGS Platform
YeasenHighlights: fast enzymatic digestion method for DNA library preparation · ultra-fast RNA library preparation · co-library technology that can distinguish between DNA and RNA sources.
images/molecular-biology/yeasen-ngs-platform.jpgmRNA Preparation Platform
YeasenPost-transcriptional capping and co-transcriptional capping routes, supported by mRNA stock solution preparation and analysis technology and mRNA LNP preparation and evaluation technology.
images/molecular-biology/yeasen-mrna-capping.jpgTechnologies
Hieff Trans™ Advanced R&D Platform
YeasenAI-powered novel transfection reagent development platform – core R&D strengths powered by high-throughput compound library screening.
images/molecular-biology/yeasen-hieff-trans-figure.jpg■Qualification
UCF.ME: Ultra Clean Molecular Enzyme Factory
QualificationThe molecular enzymes were manufactured through high density fermentation and ultra-clean production process ensuring the cleanliness (DNA/RNA free, endotoxin free, sterile etc.) of enzymes following the ISO13485 quality management system.
images/molecular-biology/yeasen-ucf-me-fermentation.jpg
images/molecular-biology/yeasen-ucf-me-cleanroom.jpgmRNAtools Manufacture Factory
QualificationWith an area of more than 5,000 square meters, the plant is equipped with automatic fermentation equipment and industrial-grade purification and freeze-drying facilities.
images/molecular-biology/yeasen-mrnatools-factory.jpgDMF Filing
QualificationCompleted DMF (drug master file) filing of several products.
DMF filings10 items
| S/N | Product Name | Application Number |
|---|---|---|
| 1 | T7 RNA Polymerase | MF037035 |
| 2 | UltraNuclease GMP-grade | MF037298 |
| 3 | mRNA Vaccinia Capping Enzyme GMP-grade | MF037433 |
| 4 | mRNA Cap 2’-O-Methyltransferase GMP-grade | MF037434 |
| 5 | Pyrophosphatase, Inorganic GMP-grade | MF037545 |
| 6 | Murine RNase inhibitor GMP-grade | MF037546 |
| 7 | BspQI GMP-grade | MF037607 |
| 8 | Deoxyribonuclease I (DNaseI) GMP-grade | MF037744 |
| 9 | Salt Active UltraNuclease GMP-grade | MF037815 |
| 10 | PEI Transfection Reagent | MF038217 |